| |
| |
|
| Insider
Information: |
Shafer Bradford J |
| Relationship: |
EVP, Gen. Counsel, Sec... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
720,844 |
|
|
Indirect Shares
|
8,250 |
|
|
| Direct
Value |
$9,745,773 |
|
|
|
Indirect Value
|
$132,908 |
|
|
| Total
Shares |
729,094 |
|
|
| Total
Value |
$9,878,680 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Innoviva Inc |
INVA |
Sr VP, Gen. Counsel, S... |
2014-08-20 |
443,013 |
2014-08-12 |
8,250 |
Premium* |
|
|
Theravance Biopharma, Inc. |
TBPH |
EVP, Gen. Counsel, Sec... |
2021-08-20 |
277,831 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TBPH |
Theravance Biopharma, Inc... |
Sr VP, Gen. Counsel, Secretary |
• – – |
2015-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
120,000 |
163,762 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
119,000 |
294,334 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2016-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
115,000 |
251,165 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2011-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
112,500 |
370,174 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
112,250 |
189,244 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2014-03-03 |
4 |
OE |
$9.69 |
$937,488 |
D/D |
96,773 |
392,537 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2014-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
71,000 |
412,398 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2014-03-03 |
4 |
AS |
$36.72 |
$2,417,314 |
D/D |
(65,806) |
326,731 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2021-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
316,916 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2006-05-03 |
4 |
OE |
$3.10 |
$189,989 |
D/D |
40,761 |
271,735 |
|
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2014-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
364,231 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2016-08-22 |
4 |
S |
$27.16 |
$1,007,038 |
D/D |
(37,078) |
195,730 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2009-03-20 |
4 |
A |
$0.00 |
$0 |
D/D |
37,000 |
229,690 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2008-07-30 |
4 |
S |
$15.97 |
$553,689 |
D/D |
(34,676) |
193,268 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
33,750 |
165,276 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2014-08-11 |
4 |
OE |
$14.53 |
$489,182 |
D/D |
33,667 |
474,430 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2021-02-20 |
4 |
D |
$18.79 |
$598,819 |
D/D |
(31,869) |
285,047 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2013-06-07 |
4 |
S |
$35.04 |
$1,087,572 |
D/D |
(31,038) |
303,416 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2011-11-28 |
4 |
OE |
$8.53 |
$257,649 |
D/D |
30,205 |
370,673 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2020-02-20 |
4 |
D |
$25.90 |
$761,512 |
D/D |
(29,402) |
264,932 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2014-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
28,365 |
440,763 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2014-08-11 |
4 |
S |
$22.12 |
$599,629 |
D/D |
(27,108) |
447,322 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2017-03-03 |
4 |
S |
$31.86 |
$854,772 |
D/D |
(26,829) |
161,453 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
EVP, Gen. Counsel, Secretary |
• – – |
2018-08-08 |
4 |
S |
$27.85 |
$706,182 |
D/D |
(25,355) |
98,124 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr VP, Gen. Counsel, Secretary |
• – – |
2007-10-31 |
4 |
S |
$25.00 |
$625,000 |
D/D |
(25,000) |
222,568 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
